The prospects for a one-time treatment that reduces the risk of heart disease for the rest of a person’s life just got ...

Munich news, health insurance, technology, jobs and other topics for expatriates. The Eye Newspapers covers daily news and offers services for foreigners.

FRIDAY, March 28, 2025 (HealthDay News) -- Combination lipid-lowering therapy (LLT) is associated with a greater reduction in low-density lipoprotein cholesterol (LDL-C) compared with statin ...

Currently available lipid-lowering therapies provide benefit, however there are a large number of patients globally who do not achieve their LDL-C goal with such treatments, in addition to many ...

One in four patients who present with elevated low-density lipoprotein cholesterol levels have no documented use of statin therapy, according to a study published April 16 in Epic Research.  Here are ...

Patients who receive a combination of drugs shortly after a heart attack experience significantly better outcomes than those ...

A greater reduction LDL-C was seen for combo therapy; reductions also seen in all-cause mortality, major adverse CV events, stroke incidence. HealthDay News — Combination lipid-lowering therapy ...

Statins have been used safely for years. They help to lower LDL-C "bad" cholesterol by reducing the production of it by the ...

The largest study to date suggests that patients at high risk for heart attacks and strokes should begin immediate treatment ...

The results show dose-dependent LDL-lowering and, in contrast to what was seen previously with VERVE-101, no safety issues.

In a Phase Ib trial, VERVE-102 showed it could lower bad cholesterol across doses, setting up an opt-in decision for Eli ...